Sha, Xue
Gong, Guanzhong
Qiu, Qingtao
Duan, Jinghao
Li, Dengwang
Yin, Yong
Funding for this research was provided by:
Key Technology Research and Development Program of Shandong (2018GSF118006)
Article History
Received: 9 July 2019
Accepted: 27 January 2020
First Online: 5 February 2020
Ethics approval and consent to participate
: The Ethics Committee (IRB) at Shandong Cancer Hospital and Institute reviewed and discussed the protocol and other aspects of this research. After a vote (Total 11, Agree 11, Disagree 0), the IRB agreed that the study followed the guidelines of good clinical practice (GCP) and that the trial could be conducted at Shandong Cancer Hospital and Institute (NO. 201805056).
: The personal/clinical data had been obtained consent for publication from participants.
: The authors declare that they have no competing interests.